REDS Banner Logo

REDS-III Domestic Sites

REDS-III provides support for four research sites within the United States which are referred to as Domestic Hubs. Each Hub has a blood center and transfusion services that serve specialty care and community hospitals.



Blood Center of WisconsinOffsite icon

Alan E. Mast, MD, PhD
Principal Investigator, BloodCenter of Wisconsin

Jerome L. Gottschall, MD
Co-Principal Investigator, BloodCenter of Wisconsin

BCW Image       BCW Image 
  • Froedtert Hospital
  • Marshfield Clinic/Saint Joseph's Hospital
  • Aurora Saint Luke's Hospital
  • Aurora Sinai Hospitals




Institute for Transfusion MedicineOffsite icon

Darrell J. Triulzi, MD
Principal Investigator, ITxM

Joseph E. Kiss, MD
Co-Principal Investigator, ITxM

Ronald G. Strauss, MD
Co-Principal Investigator, ITxM

ITxM Image        ITxM Image 
  • UPMC Presbyterian
  • UPMC Shadyside
  • UPMC St. Margaret




University of California at San FranciscoOffsite icon and Blood Systems Research InstituteOffsite icon

Edward L. Murphy, MD, MPH
Principal Investigator, UCSF and Blood Systems Research Institute

Elizabeth St. Lezin, MD 
Co-Principal Investigator UCSF/San Francisco VA Medical Center

UCSF Image  UCSF Image
BSRI Image 
  • UCSF Medical Center
  • San Francisco General Hospital
  • San Francisco VA Medical Center




YaleOffsite icon and American Red CrossOffsite icon

Edward Snyder, MD
Principal Investigator, Yale New Haven Hospital

Ritchard Cable, MD
Co-Principal Investigator, American Red Cross

Yale Image        RedCross Image    Yale Red Cross Image 
  • Bridgeport Hospital
  • Yale-New Haven Hospital



Hubs participate in three general areas of research related to blood banking and transfusion medicine:

  • Studies addressing blood donors, including evaluating donors’ health to learn their iron status, assessing the prevalence of infectious agents in blood donors, and improving donor screening techniques;

  • Studies to optimize blood banking practices, including refinements to existing approaches and developing strategies to enhance blood collection, laboratory screening, and processing;

  • Studies addressing transfusion practices, including evaluation of blood product use in various clinical settings; non-infectious and infectious complications of transfusion; and clinical outcomes in patient populations that receive specific blood products.


Back to topBack to top


REDS-III HOME | ACCESSIBILITY | READERS & PLAYERS | SITE INDEX | OTHER SITES | PRIVACY STATEMENT | FOIA | CONTACT US | OIG

National Institutes of Health    Department of Health and Human Services    USA.gov